Pediatrics and neonatology · 2026
Post-acute sequelae of COVID in children: Pulmonary assessment using impulse oscillometry and the effect of vaccination.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Chieh-Ho, Chen Pei-Chi, Liu Xiao-Ling, Wei Chi-Hung, Hsu Yu-Lung, Lin Chien-Heng, Soong Wen-Jue, Shih-Hsin Wu Lawrence, Tsai Hui-Ju, Chang Sheng-Mao, Wang Jiu-Yao
Аннотация
BACKGROUND: Post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID syndrome (LCS), is characterized by persistent symptoms following SARS-CoV-2 infection and poses significant health challenges, particularly impacting pulmonary function in children. This study aims to evaluate the effect of COVID-19 vaccination on pulmonary function in children with PASC using standardized spirometry and impulse oscillometry (IOS).
METHODS: This prospective, observational study was conducted from July to September 2022, at the tertiary medical center of a children's hospital in Taiwan. Pediatric patients aged 6 to 18 years diagnosed with PASC were enrolled. Demographic data, vaccination status, and blood test results were collected. Pulmonary function was assessed using spirometry and IOS, measuring parameters such as respiratory resistance (R5, R20) and reactance (X5). Statistical analyses explored the association between IOS results and clinical symptoms, as well as vaccination status.
RESULTS: Among 209 children, 78.7% were vaccinated. IOS detected abnormalities in 74.6%, with 12.0% diagnosed with obstructive lung disease (OLD) and 62.9% with small airway disease (SAD). Fatigue (56.0%) and dyspnea (52.0%) were most common in OLD, while chest pain (45.0%) and cough (41.7%) prevailed in SAD. Vaccinated children showed significantly lower respiratory resistance (R5, R20, p < 0.01) and improved reactance (X5, p < 0.001). Vaccination did not significantly reduce respiratory-related symptoms but it was associated with lower risks of decreased appetite (OR = 0.399) and sleep disturbance (OR = 0.345).
CONCLUSION: COVID-19 vaccination may have a protective effect on pulmonary function in children with PASC, highlighting its mitigation of long-term respiratory complications. Further studies are needed to explore underlying mechanisms.
METHODS: This prospective, observational study was conducted from July to September 2022, at the tertiary medical center of a children's hospital in Taiwan. Pediatric patients aged 6 to 18 years diagnosed with PASC were enrolled. Demographic data, vaccination status, and blood test results were collected. Pulmonary function was assessed using spirometry and IOS, measuring parameters such as respiratory resistance (R5, R20) and reactance (X5). Statistical analyses explored the association between IOS results and clinical symptoms, as well as vaccination status.
RESULTS: Among 209 children, 78.7% were vaccinated. IOS detected abnormalities in 74.6%, with 12.0% diagnosed with obstructive lung disease (OLD) and 62.9% with small airway disease (SAD). Fatigue (56.0%) and dyspnea (52.0%) were most common in OLD, while chest pain (45.0%) and cough (41.7%) prevailed in SAD. Vaccinated children showed significantly lower respiratory resistance (R5, R20, p < 0.01) and improved reactance (X5, p < 0.001). Vaccination did not significantly reduce respiratory-related symptoms but it was associated with lower risks of decreased appetite (OR = 0.399) and sleep disturbance (OR = 0.345).
CONCLUSION: COVID-19 vaccination may have a protective effect on pulmonary function in children with PASC, highlighting its mitigation of long-term respiratory complications. Further studies are needed to explore underlying mechanisms.